HDAC Inhibitor Market is expanding as researchers investigate the relationship between epigenetic changes and resistance to cancer treatment. HDAC inhibitors may offer opportunities for combination strategies designed to address specific mechanisms of therapeutic resistance. The HDAC Inhibitor Market was valued at US$ 1.42 billion in 2025 and is projected to reach US$ 2.65 billion by 2034,...